Torrent Pharmaceuticals Ltd. — Call Transcript 2022

May 25, 2022

�;orrent W PHARmA

25[th ] May, 2022

The Dy. General Manager (Listing Dept.) BSE Limited, Corporate Relationship Dept., 1[st ] Floor, New Trading Ring, P. J. Towers, Dalal Street, Fort, Mumbai - 400 001 (BSE Scrip Code: 500420)

The Manager - Listing Dept., National Stock Exchange oflndia Ltd., Exchange Plaza, 5[th ] Floor, Plot No. C/1, G. Block, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 051 (NSE Scrip Code: TORNTPHARM)

Dear Sir,

Sub.: Audio Recording of Conference call wit'1 Analysts / Investors on Audited Financial Results for the quarter and year ended 31[st ] March, 2022

In continuation of our letter dated 20-May-22 and pm'suant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirem�nts) Regulations, 2015, the audio recording of Conference call with Analysts / Investors on Audited Financial Results of the Company for the quarter and year ended 31[st ] March, 2022, has been placed on the Company's website at https://www.torrentphanna.com/pdf/investors/ Audio Recording31032022.mp3

Thanking you,

Yours sincerely,

For TORRENT PHARMACEUTICALS LIMITED

==> picture [103 x 30] intentionally omitted <==

MAHESH AGRA WAL VP (LEGAL) & COMPANY SECRETARY

TORRENT PHARMACEUTICALS LIMITED

GIN: L24230GJ1972PLC002126

Reg.Office: Torrent House, Off Ashram Road, Ahmedabad • 380 009, India. Phone: +91 79 26599000, Fax: +917926582100, www.torrentpharma.com